Engineering of cells and tissues for treatment of erectile dysfunction

World Journal of Urology

Volumn 19, Issue 1, 2001, Pages 67-73

  Atala, A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; CYTOLOGY; HISTOLOGY; HUMAN; IMPOTENCE; MALE; PENIS; PENIS PROSTHESIS; REVIEW;

BIOMEDICAL ENGINEERING; HUMANS; IMPOTENCE; MALE; PENILE PROSTHESIS; PENIS;

EID: 0035259057     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450000170     Document Type: Article

References (41)

1. Padma-Nathan H, Goldstein I, Azadzoi K, Blanco R, Saenz de Tejada I, Krane RJ (1986) In vivo and in vitro studies on the physiology of penile erection. Semin Urol 4: 209-216
2. Melman A, Gingell JC (1999) The epidemiology and pathophysiology of erectile dysfunction. J Urol 161: 5-11
3. Montague DK, Barada JH, Belker AM, Levine LA, Nadig PW, Roehrborn CG, Sharlip ID, Bennett AH (1996) Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. J Urol 156: 2007-2011
4. Brelan PN Jr (1989) History of prosthetic treatment of impotence. In: Montague DK (ed) Genitourinary prostheses. Saunders, Philadelphia
5. Small MP. Carrion HM, Gordon JA (1975) Small-Carrion penile prosthesis: new implant for management of impotence. Urology 5: 479
6. Nukui F, Okamoto S, Nagata M, Kurokawa J, Fukui J (1997) Complications and reimplantation of penile implants. Int J Urol 4: 52
7. Thomalla JV, Thompson ST, Rowland RG, Mulcahy JJ (1987) Infectious complications of penile prosthetic implants. J Urol 138: 65-67
8. Vickers KE, Vickers MA (1996) Has the efficacy of penile arterial by-pass surgery in the treatment of arteriogenic erectile dysfunction been determined? Int J Impôt Res 8: 247-251, discussion 251 253
9. Sharaby JS. Benet AE, Melman A (1995) Penile revascularization22: 821-832
10. von Heyden B, Donatucci CF, Kaula N, Lue TF (1993) Intracavernous pharmacotheraply for impotence: selection of appropriate agent and dose. J Urol 149: 1288-1290
11. Sharlip ID (1997) Does natural erectile function improve following intracavernous injections of vasoactive drugs? Int J Impôt Res 9: 193-196
12. Peterson CA, Bennett AH, Hellstrom WJ, Kaiser FE, Morley JE, Nemo KJ, Padma-Nathan H, Place VA, Predergast JJ, Tarn PY. Tanagho EA, Todd LK, Varady JC, Gesundheit N (1998) Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations. J Urol 159: 1523-1527; discussion 1527-1528
13. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafil in the treatment of erectile dysfunction. N Eng J Med 338: 1397 04
14. Atala A, Vacanti JP, Peters CA, Mandell J, Retik AB, Freeman MR (1992) Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol 148: 658
15. Atala A, Freeman MR, Vacanti JP, Shepard J, Retik AB (1993) Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J Urol 150: 608
16. Atala A (1997) Tissue engineering in the genitourinary system. In: Atala A, Mooney D (eds) Synthetic biodegradable polymer scaffolds. Birkhauser, Boston
17. Yoo JJ, Meng J, Oberpenning F, Atala A (1998) Bladder augmentation using allogenic gladder submucosa seeded with cells. Urology 51: 221
18. Oberpenning F, Meng J, Yoo JJ, Atala A (1999) Bladder Replacement with Tissue-Engineered Neo-Organs. Nat Biotechnol 17: 149-155
19. Atala A (1996) Replacement of urologie associated mucosa. J Urol 156: 338
20. Machlouf M, Atala A (1998) Progress in tissue engineering: Emerging concepts for tissue and organ transplantation. Graft 1: 31
21. Wesoloski SA, Fries CC, Karlson KE, et al (1961) Porosity: primary determinant of ultimate fate of synthetic vascular grafts. Surgery 50: 91
22. Mikos AG, Sarakinos G, Lymna MD, et al (1993) Prevascularization of porous biodegradable polymers. Biotechnol Bioeng42: 716
23. Kershen RT, Yoo JJ, Moreland RB, Krane RJ, Atala A (1998) Novel system for the formation of human corpus cavernosum smooth muscle tissue in vivo. J Urol 159 [Suppl]: 156
24. Park HJ, Yoo JJ, Kershen RT, Moreland R, Atala A (1999) Reconstruction of human coporal smooth muscle and endothelial cells in vivo. J Urol 162: 1106-1109
25. Falke G, Yoo J, Machado M, Moreland R, Atala A (1999) Corporal tissue for penile reconstruction. Pediatrics 104: 840
26. Yoo J, Lee I, Atala A (1998) Cartilage rods as a potential materai for penile reconstruction. J Urol 160: 1164
27. Yoo J, Park H, Lee I, Atala A (1999) Autologous engineered cartilage rods for penile reconstruction. J Urol 162: 1119-1121
28. Atala A, Cima L, Kim W, Paige K, Vacanti JP, Retik AB. Vacanti CA (1993) Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol 150: 745-747
29. Atala A, Kim W, Paige K, Vacanti CA, Retik AB (1994) Endoscopie treatmentof vesicoureteral reflux with a chrondrocyte-alginate suspension. J Urol 152: 641-643
30. Kershen R, Atala A (1999) New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin North Am 26: 81-94
31. Klagsbrun M, D'Amore PA (1991) Regulation of angiogenesis. Annu Rev Physiol 53: 217
32. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during a tumorigenesis. Cell 86: 353
33. Risau W (1997) Mechanisms of angiogenesis. Nature 386: 671
34. Polverini PJ (1996) The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 6: 230
35. Bauters C, Asahara T, Zheng LP, et al (1994) Physiological assessment of augmented vascularity induced by VEGF in ischémie rabbit hindlimb. Am J Physiol 267: 263
36. Taub PJ, Marmur JD, Zhang WX, et al (1998) Locally administered vascular endothelial growth factor cDNA increases survival of ischémie experimental skin flaps. Plast Reconstr Surg 102: 2033
37. Takeshita S, Tsurumi Y, Couffinahl T, et al (1996) Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 75: 487
38. Isner JM, Losordo DW (1999) Theraputic angiogenesis for heart failure. Nat Med 5: 491
39. Soker S, Fidder H, Neufeld G, Klagsbrun M (1996) Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. Biol Chem 271: 5761
40. Machluf M, Amiel G, Soker S, Atala A (2000) A novel system for the enhancement of angiogenesis to free grafts using encapsulated cells engineered to secrete VEGF. J Urol 305S: 70
41. Yoo JJ, Atala A (1997) A novel gene delivery system using urothelial tissue engineered neo-organs. J Urol 158: 1066